Eleonora Distrutti
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Spleen stiffness measurement by transient elastography for detecting esophagogastric varices: a systematic review of diagnostic accuracy studies.
Journal: European review for medical and pharmacological sciences
Published: July 31, 2026
Bile acids as mediators of microbiota signaling in entero-hepatic disorders.
Journal: Biochemical pharmacology
Published: July 02, 2026
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy.
Journal: Biochemistry and biophysics reports
Published: May 11, 2026
Eosinophilic Esophagitis and Lymphocytic Esophagitis: Convergent Symptoms, Divergent Biology.
Journal: Recent advances in inflammation & allergy drug discovery
Published: March 06, 2026
Secondary bile acids and host metabolism: crosstalk, signaling pathways and therapeutic frontiers.
Journal: European review for medical and pharmacological sciences
Published: January 05, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer.
Journal: Cells
Published: December 29, 2025
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma.
Journal: Biochemical pharmacology
Published: December 01, 2025
Secondary bile acids as immune and metabolic mediators.
Journal: Trends in immunology
Published: October 15, 2025
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancer.
Journal: Translational oncology
Published: August 22, 2025
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 15, 2025
Last Updated: 09/26/2026